Haleos Labs enters into strategic Development collaboration with HRV Global

21 Jan 2026 Evaluate

Haleos Labs has entered into strategic Development collaboration with HRV Global Life Sciences (HRV Global) to accelerate development and GMP manufacturing of orphan drug and niche therapeutic Active Pharmaceutical Ingredients (APls) for regulated and semi-regulated markets

The company will leverage its USFDA-GMP aligned systems and API manufacturing expertise. HRV Global will contribute its global market access and regulatory execution capabilities. This collaboration supports the company's strategic goal to expand into complex and high value APls catering to underserved therapeutic segments and strengthens the company' presence in regulated and semi regulated markets including US, EU, Latin America, MENA and APAC, through coordinated development and regulatory pathways.

Haleos Labs (formerly known as SMS Lifesciences India) is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, API and Intermediates.


Haleos Labs Share Price

1250.00 43.95 (3.64%)
22-Jan-2026 16:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1374.60
Zydus Lifesciences 883.85
Lupin 2165.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×